PIK3CA and colorectal cancer: In conclusion, the impact and mechanism of PIK3CA gene mutation on tumor-associated antigen vaccines or cell therapy in colorectal cancer is complex, involving multiple aspects such as tumor cells, immune cells, signaling pathways, and the tumor microenvironment.